Stocks Health care STE
NYSE · Health careSTERIS plc (STE)
STERIS plc brought in $6.2B of revenue over the twelve months to September 30, 2026, up 8.1% from a year earlier. Net income was $826.8M, a net margin of 13.4%. Operating cash flow minus capital spending left $972.4M of free cash flow in fiscal 2026. At September 30, 2026 it held $531.1M in cash against $1.7B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.
Key facts about STERIS plc
- Net worth
- STERIS plc has a market value (market cap) of $25.1B at the latest share price, and shareholders' equity of $7.3B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $5.9B (+8.7% year on year), with net income of $782.3M. Over the 12 months to September 30, 2026: revenue $6.2B, net income $826.8M.
- Cash flow
- In fiscal 2026 operations brought in $1.3B of cash; after $369M of capital spending, free cash flow was $972.4M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- STERIS plc's next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
- Dividend
- STERIS plc declared dividends of $2.46 per share in fiscal 2026, a yield of 0.96% at the current price.
What STERIS plc does
STERIS plc is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NYSE under the ticker STE.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $5.9B | $782.3M | $7.93 | $972.4M |
| 2025 | $5.5B | $614.6M | $6.20 | $778M |
| 2024 | $5.1B | $378.2M | $3.81 | $613M |
| 2023 | $4.5B | $107M | $1.07 | $395M |
| 2022 | $4.2B | $243.9M | $2.48 | $397.2M |
| 2021 | $3.1B | $397.4M | $4.63 | $450.4M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where STE ranks in Health care
Dividends
STERIS plc declared $2.46 per share in fiscal 2026. At the current price that is a yield of 0.96%. It paid out $241.8M in cash dividends, 31% of its net income.
| Fiscal year | Per share | Paid out | Of profit |
|---|---|---|---|
| 2026 | $2.46 | $241.8M | 31% |
| 2025 | $2.23 | $219.9M | 36% |
| 2024 | $2.03 | $200.6M | 53% |
| 2023 | $1.84 | $183.5M | 171% |
| 2022 | $1.69 | $163.2M | 67% |
| 2021 | $1.57 | $133.8M | 34% |
Latest SEC filings
What STERIS plc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 6, 2026
- November 5, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 8.8% to $1.6B versus the same quarter last year; net income rose 11% to $213.7M.
- November 4, 2026
- November 4, 2026
- October 13, 2026
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 7.3% to $1.5B versus the same quarter last year; net income rose 13% to $200.1M.
- August 6, 2026
- August 6, 2026
- August 5, 2026
- June 16, 2026
What is STE worth? A DCF from its reported cash flow
Insider trades
What the people running STERIS plc did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 1, 2026 | Burton Karen LSr. Vice Pres., CFO | Shares withheld for tax | 228 | - |
| August 12, 2026 | Sohi MohsenDirector | Exercised options | 4,058 | $349.9K |
| August 12, 2026 | Sohi MohsenDirector | Sold | 4,058 | $956.8K |
| July 1, 2026 | Sohi MohsenDirector | Exercised options | 3,781 | $270K |
| July 1, 2026 | Sohi MohsenDirector | Shares withheld for tax | 1,837 | $390K |
| June 15, 2026 | Zangerle John AdamSr. VP, Gen Counsel, and Sec. | Soldpre-planned (10b5-1) | 1,419 | $297K |
| June 5, 2026 | Carestio Daniel APresident and CEO, Director | Soldpre-planned (10b5-1) | 1,374 | $291.3K |
| June 4, 2026 | Burton Karen LSr. Vice Pres., CFO | Shares withheld for tax | 90 | $19.1K |
Who owns STE
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Vanguard Capital Management13G, passive | 7.48% | April 30, 2026 |
| Vanguard Portfolio Management13G, passive | 5.05% | April 29, 2026 |
Largest institutional holders
Insiders
12 insiders reported holding 242,329 shares in total, about $62.3M at the last price.
| Holder | Shares |
|---|---|
| Carestio Daniel APresident and CEO, Director | 63,647 |
| Breeden Richard CDirector | 38,964 |
| Zangerle John AdamSr. VP, Gen Counsel, and Sec. | 35,259 |
| Sohi MohsenDirector | 24,305 |
| Majors Cary LSVP and President, Healthcare | 17,338 |
| Fraser Mary ClareSVP & Chief HRO | 13,716 |
| Burton Karen LSr. Vice Pres., CFO | 12,956 |
| Madsen JuliaSr. VP and GM, Life Sciences | 12,257 |
| Kohler Kenneth ESVP & GM, AST | 11,332 |
| Tamaro RenatoV.P. & Corporate Treasurer | 6,194 |
Questions about STE
What does STERIS plc do?
STERIS plc is a company in the Health care sector, listed on NYSE as STE. Its shares trade on NYSE under the ticker STE.
What is STERIS plc's net worth?
STERIS plc has a market value (market cap) of $25.1B at the latest share price, and shareholders' equity of $7.3B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is STERIS plc profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $826.8M on revenue of $6.2B, a net margin of 13.4%.
How much revenue does STERIS plc make?
Over the twelve months to September 30, 2026 STERIS plc reported revenue of $6.2B. That is 8.1% more than a year earlier.
When did STERIS plc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the shelf registration to sell securities from November 6, 2026.
When is STERIS plc's next earnings report?
STERIS plc's next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Does STERIS plc pay a dividend?
Yes. STERIS plc declared dividends of $2.46 per share in fiscal 2026, a yield of 0.96% at the current price.
Similar companies
Compare STE with
Follow STE
Get an email when STERIS plc files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values STERIS plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.